These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6123701)

  • 21. [Inflammatory mediators in the pathogenesis of obstructive bronchial diseases: consequences for therapy].
    Hahn HL
    Verh Dtsch Ges Inn Med; 1988; 94():364-75. PubMed ID: 2905102
    [No Abstract]   [Full Text] [Related]  

  • 22. Should long-acting beta 2-agonists be considered an alternative first choice option for the treatment of stable COPD?
    Cazzola M; Matera MG
    Respir Med; 1999 Apr; 93(4):227-9. PubMed ID: 10464885
    [No Abstract]   [Full Text] [Related]  

  • 23. Indications for beta-adrenergic drugs in the treatment of respiratory insufficiency.
    Brouet G; Ruff F
    Minerva Med; 1976 Mar; 67(15):926-9. PubMed ID: 4749
    [No Abstract]   [Full Text] [Related]  

  • 24. Considerations in office management of chronic obstructive pulmonary disease.
    Schwartz AM
    J Am Osteopath Assoc; 1981 Aug; 80(12 Suppl):866-9. PubMed ID: 6115835
    [No Abstract]   [Full Text] [Related]  

  • 25. [Asthma: theory and practice in the year 1992].
    Sterk PJ; Bel EH; Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1992 Mar; 136(10):451-5. PubMed ID: 1347645
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes of therapeutic dogma in obstructive lung diseases].
    Płusa T
    Pol Merkur Lekarski; 2003 Jun; 14(84):672-3. PubMed ID: 14524300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of salbutamol on pulmonary circulation, ventilation and gas exchange in patients with chronic obstructive airways disease. Preliminary report.
    Koziorowski A; Zielinski J; Maszczyk Z; Pawlicka L; Klimkiewicz H
    Bull Physiopathol Respir (Nancy); 1972; 8(3):611-6. PubMed ID: 4405131
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta-adrenoceptor agonists and obstructive airways disease.
    Ind PW
    Lancet; 1982 Aug; 2(8294):388. PubMed ID: 6124789
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bronchodilator treatment of chronic obstructive bronchopneumopathies].
    Meslier N; Racineux JL
    Rev Mal Respir; 1993; 10(2):79-85. PubMed ID: 8099224
    [No Abstract]   [Full Text] [Related]  

  • 30. Salmeterol for emphysema?
    Healey D
    Aust Fam Physician; 1996 Aug; 25(8):1340. PubMed ID: 8771895
    [No Abstract]   [Full Text] [Related]  

  • 31. [Staged therapy of chronic obstructive respiratory tract diseases. Treatment of chronic obstructive respiratory tract diseases by the established physician].
    Hausen T
    Fortschr Med; 1989 Mar; 107(9):210-3. PubMed ID: 2566567
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk/benefit ratio of long-term treatment with beta 2-adrenoceptor agonists.
    Ziment I
    Lung; 1990; 168 Suppl():168-76. PubMed ID: 1974672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination bronchodilator therapy in COPD.
    Rennard SI
    Chest; 1995 May; 107(5 Suppl):171S-175S. PubMed ID: 7743822
    [No Abstract]   [Full Text] [Related]  

  • 34. The beta-agonist controversy. Impact in COPD.
    Ziment I
    Chest; 1995 May; 107(5 Suppl):198S-205S. PubMed ID: 7743827
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inhalational anticholinergic versus inhaled beta-mimetic drugs in COPD].
    Lode H
    Internist (Berl); 1999 Jan; 40(1):114. PubMed ID: 10086312
    [No Abstract]   [Full Text] [Related]  

  • 36. [Beta-2-agonists are still of value. Tolerance does not affect the bronchodilating effect].
    Larsson K
    Lakartidningen; 1997 Oct; 94(42):3741-2, 3745-6, 3749-50. PubMed ID: 9411129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Appleton S; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recommendations for a graduated system of long-term drug therapy of obstructive respiratory tract diseases].
    Dtsch Med Wochenschr; 1984 Mar; 109(10):392-5. PubMed ID: 6141925
    [No Abstract]   [Full Text] [Related]  

  • 39. Nebulisers for chronic obstructive pulmonary disease.
    O'Driscoll BR
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S49-52. PubMed ID: 9155851
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: The Pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.
    Wein AJ
    J Urol; 2015 Jan; 193(1):218-9. PubMed ID: 25523672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.